Alcon Inc. (ALC)

CH — Healthcare Sector
Peers: TFX  WST  RMD  ICUI  COO  ANGO  ATR  BLFS  HAE  MMSI  NVST  EMBC  BAX 

Automate Your Wheel Strategy on ALC

With Tiblio's Option Bot, you can configure your own wheel strategy including ALC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ALC
  • Rev/Share 20.2443
  • Book/Share 44.689
  • PB 1.7149
  • Debt/Equity 0.2375
  • CurrentRatio 2.6015
  • ROIC 0.0424

 

  • MktCap 37861152000.0
  • FreeCF/Share 3.2276
  • PFCF 23.688
  • PE 35.3424
  • Debt/Assets 0.1673
  • DivYield 0.0044
  • ROE 0.0493

 

  • Rating B
  • Score 3
  • Recommendation Neutral
  • P/E Score 2
  • DCF Score 3
  • P/B Score 3
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade ALC JP Morgan Overweight Neutral -- -- Aug. 21, 2025
Downgrade ALC Deutsche Bank Buy Hold -- -- May 20, 2025
Reiterated ALC BTIG Research -- Buy $102 $99 May 14, 2025
Reiterated ALC Needham -- Buy $107 $110 March 28, 2025
Upgrade ALC BofA Securities Neutral Buy -- -- March 25, 2025
Reiterated ALC Needham -- Buy $108 $106 Jan. 24, 2025
Upgrade ALC Redburn Atlantic Neutral Buy -- -- Jan. 10, 2025
Reiterated ALC Needham -- Buy $103 $108 Dec. 17, 2024
Upgrade ALC Redburn Atlantic Sell Neutral -- -- Oct. 10, 2024
Upgrade ALC RBC Capital Mkts Sector Perform Outperform -- -- Sept. 10, 2024

News

Here's Why Alcon (ALC) is a Strong Momentum Stock
ALC
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More
image for news Here's Why Alcon (ALC) is a Strong Momentum Stock
Broadwood Partners Comments on STAAR Surgical's Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon
ALC, STAA
Published: October 14, 2025 by: Business Wire
Sentiment: Neutral

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the recent Current Report on Form 8-K filed by STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) with the U.S. Securities and Exchange Commission (“SEC”) of a “supplement” to the Company's definitive proxy statement, filed on September 16, 2025, in connection with the proposed acquisition of STAAR by Alcon Inc. (“Alcon”) (NYSE: ALC). Broadwood, which owns 27.5% of STAAR.

Read More
image for news Broadwood Partners Comments on STAAR Surgical's Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card
ALC, STAA
Published: October 08, 2025 by: Business Wire
Sentiment: Neutral

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today provided the following statement in response to a report issued by Glass, Lewis & Co., LLC (“Glass Lewis”) related to STAAR's pending merger with Alcon (SIX/NYSE: ALC): The STAAR Board of Directors and management team strongly disagree with the recommendation issued by Glass Lewis.

Read More
image for news STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon
ALC, STAA
Published: October 07, 2025 by: PRNewsWire
Sentiment: Neutral

CHARLOTTE, N.C. , Oct. 7, 2025 /PRNewswire/ -- Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approximately 1.5% of the Company's outstanding common stock, today issued the following statement outlining its opposition of the proposed acquisition of STAAR by Alcon Inc. ("Alcon") (NYSE: ALC): We have been significant STAAR shareholders for more than ten years and remain convicted in the significant value of the Company.

Read More
image for news Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon
Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical
ALC, STAA
Published: October 03, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP continues its investigation into whether the board members of STAAR Surgical Company (NASDAQ: STAA) breached their fiduciary duties in connection with the proposed sale of the Company to Alcon (NYSE: ALC).

Read More
image for news Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical
Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical's Sale to Alcon
ALC, STAA
Published: October 03, 2025 by: Business Wire
Sentiment: Neutral

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today announced that it has published a presentation outlining why stockholders should vote on Broadwood's GREEN Proxy Card “AGAINST” the proposed acquisition of the Company by an affiliate of Alcon Inc. (NYSE: ALC) on the terms announced on August 5, 2025. The 81-pa.

Read More
image for news Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical's Sale to Alcon
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon's Acquisition of STAAR
ALC, STAA
Published: September 30, 2025 by: Business Wire
Sentiment: Neutral

GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the manufacturer of the Implantable Collamer® Lens (ICL), today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR), in connection with Alcon's acquisition of STAAR, expired at 11:59 p.m. ET on September 29, 2025. As previously announced,.

Read More
image for news Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon's Acquisition of STAAR
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
ALC
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Negative

Alcon sees growth from surgical innovation and vision care products, but faces macro pressures and fierce competition.

Read More
image for news Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon's UNITY VCS Shows Superior Efficiency in Studies, Stock Up
ALC
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive

ALC's UNITY VCS shows faster, more efficient cataract and vitreoretinal surgery results, lifting shares after study presentations.

Read More
image for news Alcon's UNITY VCS Shows Superior Efficiency in Studies, Stock Up
STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
ALC, STAA
Published: September 16, 2025 by: Business Wire
Sentiment: Neutral

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connection with the Company's pending merger with Alcon (SIX/NYSE: ALC). STAAR will hold a Special Meeting of Stockholders on October 23 at 8:30 a.m. (Pacific Time) to vote to adopt the.

Read More
image for news STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical
ALC, STAA
Published: September 09, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP continues its investigation into whether the board members of STAAR Surgical Company (NASDAQ: STAA) breached their fiduciary duties in connection with the proposed sale of the Company to Alcon (NYSE: ALC).

Read More
image for news Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical
Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges
ALC
Published: August 21, 2025 by: Zacks Investment Research
Sentiment: Negative

ALC's Q2 earnings top estimates but revenues fall short, sending shares down more than 10% as margins tightened and 2025 sales outlook narrowed.

Read More
image for news Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges
Alcon: More Than Meets The Eye
ALC
Published: August 20, 2025 by: Seeking Alpha
Sentiment: Positive

Alcon remains a leader in eye care, benefiting from strong market positioning and long-term industry tailwinds like aging populations and technological advances. Recent M&A activity, including the STAAR Surgical acquisition, enhances long-term growth but pressures near-term earnings and raises valuation concerns. Despite solid sales growth and manageable debt, shares trade at a demanding 29-30x earnings multiple, which I view as fully valued given current growth rates.

Read More
image for news Alcon: More Than Meets The Eye
Stay Ahead of the Game With Alcon (ALC) Q2 Earnings: Wall Street's Insights on Key Metrics
ALC
Published: August 14, 2025 by: Zacks Investment Research
Sentiment: Neutral

Get a deeper insight into the potential performance of Alcon (ALC) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Read More
image for news Stay Ahead of the Game With Alcon (ALC) Q2 Earnings: Wall Street's Insights on Key Metrics
Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical
ALC, STAA
Published: August 05, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of STAAR Surgical Company (NASDAQ: STAA) breached their fiduciary duties in connection with the proposed sale of the Company to Alcon (NYSE: ALC).

Read More
image for news Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical
Alcon Stock Gains Following UNITY VCS' Approval in Canada
ALC
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Positive

ALC's UNITY VCS gets Canada's approval, advancing surgical precision with faster, more efficient technology.

Read More
image for news Alcon Stock Gains Following UNITY VCS' Approval in Canada
Alcon's Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval
ALC
Published: July 08, 2025 by: Business Wire
Sentiment: Neutral

TORONTO--(BUSINESS WIRE)-- #AlconCanada--Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY® Vitreoretinal Cataract System (VCS) has received Health Canada approval. This innovation is the first to be introduced from Alcon's highly anticipated Unity portfolio. “Today marks an important day for Canadian ophthalmologists as we introduce the next generation of equipment solutions in cataract and vitreoretinal surgery, and we are grateful to those who help.

Read More
image for news Alcon's Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval
Is it Apt to Retain Alcon Stock in Your Portfolio for Now?
ALC
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Negative

ALC stays on investors' radar due to its Vision Care arm's performance and contributions from new products despite macro risks and stiff competition.

Read More
image for news Is it Apt to Retain Alcon Stock in Your Portfolio for Now?
Alcon Canada Earns Global Recognition as a Top Employer
ALC
Published: June 26, 2025 by: Business Wire
Sentiment: Neutral

TORONTO--(BUSINESS WIRE)-- #AlconCanada--Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that Alcon Canada has been certified as a Top Employer in Canada by the Top Employers Institute, a recognized authority on identifying excellence in people practices and workplace culture. Being certified as a Top Employer showcases Alcon Canada's commitment to building a better world of work through exceptional HR policies and forward-thinking people practices. This recog.

Read More
image for news Alcon Canada Earns Global Recognition as a Top Employer
Gordon Schanzlin New Vision Institute Becomes First U.S. Clinic to Use Alcon's Breakthrough Unity Phaco System
ALC
Published: June 25, 2025 by: GlobeNewsWire
Sentiment: Neutral

Dr. Echegoyen Participated in Clinical Trials for the First Major Phacoemulsification Advancement in Over 15 Years Dr. Echegoyen Participated in Clinical Trials for the First Major Phacoemulsification Advancement in Over 15 Years

Read More
image for news Gordon Schanzlin New Vision Institute Becomes First U.S. Clinic to Use Alcon's Breakthrough Unity Phaco System
Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL
ALC
Published: June 20, 2025 by: Business Wire
Sentiment: Neutral

TORONTO--(BUSINESS WIRE)-- #AlconCanada--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract patients in Canada. PanOptix Pro leverages proprietary ENLIGHTEN® NXT Optical technology which delivers the lowest light scatter and highest reported light utilization of any trifocal IOL.1-3,5-9,**,‡‡ PanOptix Pro provides an unprecedented 94% light utilization, compared to a theore.

Read More
image for news Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL
Alcon Stock Rises Following the FDA Approval of TRYPTYR
ALC
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive

FDA approves ALC's TRYPTYR, a new dry eye treatment with rapid tear production. The approval is supported by strong Phase 3 trial results.

Read More
image for news Alcon Stock Rises Following the FDA Approval of TRYPTYR
Turkey Contact Lens Market - Competition, Forecast & Opportunities to 2030, Featuring Tech Contactlens, Diafarma, Alcon Laboratories, Diplomat Optics, Hoya Turkiye, ZEISS Turkiye, Keralens & more
ALC
Published: May 26, 2025 by: GlobeNewsWire
Sentiment: Neutral

The Turkish Contact Lens Market, valued at USD 55.15 Million in 2024, is set to reach USD 91.08 Million by 2030, at a CAGR of 8.68%. Growth is driven by rising vision correction awareness and demand for cosmetic lenses. The Turkish Contact Lens Market, valued at USD 55.15 Million in 2024, is set to reach USD 91.08 Million by 2030, at a CAGR of 8.68%. Growth is driven by rising vision correction awareness and demand for cosmetic lenses.

Read More
image for news Turkey Contact Lens Market - Competition, Forecast & Opportunities to 2030, Featuring Tech Contactlens, Diafarma, Alcon Laboratories, Diplomat Optics, Hoya Turkiye, ZEISS Turkiye, Keralens & more
Alcon Inc. (ALC) Q1 2025 Earnings Call Transcript
ALC
Published: May 14, 2025 by: Seeking Alpha
Sentiment: Neutral

Alcon Inc. (NYSE:ALC ) Q1 2025 Earnings Conference Call May 14, 2025 8:00 AM ET Company Participants Dan Cravens - Vice President, Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer Conference Call Participants Veronika Dubajova - Citi Jack Reynolds-Clark - RBC Capital Markets Graham Doyle - UBS Ryan Zimmerman - BTIG David Saxon - Needham & Company Larry Biegelsen - Wells Fargo Patrick Wood - Morgan Stanley Anthony Petrone - Mizuho Group Tom Stephan - Stifel Brett Fishbin - KeyBanc Capital Markets Young Li - Jefferies Jeff Johnson - Baird David Adlington - JPMorgan …

Read More
image for news Alcon Inc. (ALC) Q1 2025 Earnings Call Transcript
Alcon Q1 Earnings Miss Estimates, Stock Down, 2025 EPS View Lowered
ALC
Published: May 14, 2025 by: Zacks Investment Research
Sentiment: Negative

ALC ends the first quarter of 2025 on a disappointing note.

Read More
image for news Alcon Q1 Earnings Miss Estimates, Stock Down, 2025 EPS View Lowered
Ahead of Alcon (ALC) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ALC
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Neutral

Evaluate the expected performance of Alcon (ALC) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Read More
image for news Ahead of Alcon (ALC) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Alcon Announces Results of 2025 Annual General Meeting
ALC
Published: May 06, 2025 by: Business Wire
Sentiment: Neutral

GENEVA--(BUSINESS WIRE)--Alcon Announces Results of 2025 Annual General Meeting.

Read More
image for news Alcon Announces Results of 2025 Annual General Meeting
Alcon Announces Results of 2025 Annual General Meeting
ALC
Published: May 06, 2025 by: Business Wire
Sentiment: Neutral

GENEVA--(BUSINESS WIRE)--Alcon Announces Results of 2025 Annual General Meeting.

Read More
image for news Alcon Announces Results of 2025 Annual General Meeting
Alcon Publishes Agenda for 2025 Annual General Meeting
ALC
Published: April 04, 2025 by: Business Wire
Sentiment: Neutral

GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2025 Annual General Meeting.

Read More
image for news Alcon Publishes Agenda for 2025 Annual General Meeting
Alcon Publishes Agenda for 2025 Annual General Meeting
ALC
Published: April 04, 2025 by: Business Wire
Sentiment: Neutral

GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2025 Annual General Meeting.

Read More
image for news Alcon Publishes Agenda for 2025 Annual General Meeting

About Alcon Inc. (ALC)

  • IPO Date 2019-04-09
  • Website https://www.alcon.com
  • Industry Medical - Instruments & Supplies
  • CEO David J. Endicott
  • Employees 25599

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.